Nutrient Applications Reported by Farmers Compared with Performance‐Based Nutrient Management Plans

Bravo-Ureta, B (Bravo-Ureta, Boris)2,3;2. Univ Connecticut, Dep Agr & Resource Econ, Storrs, CT 06269 USA 3. Univ Talca, Dep Agr Econ, Talca, ChileThis study had two main objectives: (i) to evaluate how well farmers implemented nutrient management plans (NMPs) by comparing the farmers' reported practices with the recommended management for manure and fertilizer; and (ii) to evaluate whether the management of manure and fertilizer had significant effects on the nutrient status of soil and corn tissue tests. The analysis relied on data from four dairy farms that had 5 to 7 yr of records at the field level. The farmers chose to apply the recommended amount of fertilizer P from 50 to 100% of the fields. The amount applied was often only 10 to 20 kg P2O5 ha(-1) different from the recommended amount. The farmers applied the recommended amount of fertilizer N from 40 to 71% of the fields when the pre-sidedress soil nitrate test (PSNT) was used for the recommendation, but only 1 to 21% of the fields received the recommended amount when the yield goal method was used. These data suggest that the farmers trusted a fertilizer recommendation developed from a soil test more than they trusted a nonsoil test recommendation. Only a small percentage of fields (3-37%) received the recommended amount of manure N and P. Variability in the amount of residual N available from previous manure applications caused great variation in the PSNT and corn stalk nitrate values (CSNT). This variation in N availability in fields indicates that a number of years of data are needed before the PSNT and the CSNT can be used to objectively evaluate the performance of an NMP

Ketonuria is not associated with hyperemesis gravidarum disease severity

Objective: To assess the association between ketonuria and hyperemesis gravidarum (HG) disease severity. Study design: We included pregnant women hospitalised for HG who participated in the Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding (MOTHER) trial and women who were eligible, chose not to be randomised and agreed to participate in the observational cohort. Between October 2013 and March 2016, in 19 hospitals in the Netherlands, women hospitalised for HG were approached for study participation. The presence of ketonuria was not required for study entry. Ketonuria was measured at hospital admission with a dipstick, which distinguishes 5 categories: negative and 1+ through 4 + . The outcome measures were multiple measures of HG disease severity at different time points: 1) At hospital admission (study entry): severity of nausea and vomiting, quality of life and weight change compared to pre-pregnancy weight, 2) One week after hospital admission: severity of nausea and vomiting, quality of life and weight change compared to admission, 3) Duration of index hospital admission and readmission for HG at any time point. Results: 215 women where included. Ketonuria was not associated with severity of nausea and vomiting, quality of life or weight loss at hospital admission, nor was the degree of ketonuria at admission associated with any of the outcomes 1 week after hospital admission. The degree of ketonuria was also not associated with the number of readmissions. However, women with a higher degree of ketonuria had a statistically significant longer duration of hospital stay (per 1+ ketonuria, difference: 0.27 days, 95 % CI: 0.05 to 0.48). Conclusions: There was no association between the degree of ketonuria at admission and severity of symptoms, quality of life, maternal weight loss, or number of readmissions, suggesting that ketonuria provides no information about disease severity or disease course. Despite this, women with a higher degree of ketonuria at admission were hospitalised for longer. This could suggest that health care professionals base length of hospital stay on the degree of ketonuria. Based on the lack of association between ketonuria and disease severity, we suggest it has no additional value in the clinical management of HG. (C) 2020 Published by Elsevier B.V